Applications of serum amino acid levels in identification of cancer by Li, Yankun et al.
Indian Journal of Biochemistry & Biophysics 
Vol. 56, February 2019, pp. 53-56 
 
 
 
 
 
 
Applications of serum amino acid levels in identification of cancer 
Yankun Li
1, 2
*, Xinpeng Ma
1, 2
, Kenan Huang
3
 & Zhichao Bai
3 
1MOE Key Laboratory of Resources and Environmental Systems Optimization, Beijing -102 206, China 
2School of Environmental Science and Engineering, North China Electric Power University, Baoding -071 003, China 
3Oncology, 252 Hospital of Chinese People's Liberation Army, Baoding -071 000, China 
Received 06 February 2016; revised 06 November 2018 
Chemometric method of uncorrelated linear discriminant analysis (ULDA) was applied to the data of amino acid levels 
in serum of lung cancer patients and healthy people, eventually successfully classifies the samples of cancer patients and 
healthy people. Simultaneously, several potential amino acid biomarkers were possibly chosen. So the method of amino acid 
levels combined with ULDA algorithm could be applied to the identification of cancer and exploration of tumor biomarker, 
which has certain practical value and application prospects. 
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Human serum contains rich information that can 
provide important clues for cancer diagnosis and 
treatment. Compared with the tissue and cell, a serum 
sample is simple, fast and easy to be extracted and 
detected, and it brings small hurt to patients. But at 
the present, clinically early cancer screening  
method based on traditional protein tumor marker 
(TM) of serum
1-5
 including -fetoprotein (AFP), 
carcinoembryonic antigen (CEA), carbohydrate 
antigen (CA) and neuron-specific enolase (NSE) etc., 
has many problems such as low sensitivity, low 
accuracy and poor specificity. 
To solve the above problems, new highly specific 
tumor biomarkers of serum are always looked for
6
. 
Amino acid metabolism is the basis of life activities, and 
amino acid level changes in the human body are closely 
associated with many diseases. The bodies of malignant 
tumor patients mostly lie at a high metabolic state, and 
protein synthesis and catabolism in the body are 
synchronously increased. As the raw material of protein 
synthesis and product of protein catabolism, 
composition, and level of amino acid can reflect the 
metabolic state of the patients. Tumor tissues of rapid 
growth and unlimited proliferation cells need to absorb 
and consume large amounts of amino acids, which cause 
amino acid metabolism defects. The high demand of 
amino acids by malignant tumor is known as the host of 
“nitrogen trap”7,8. 
Through literature researches, it has been found that 
few papers of amino acids levels in the human body 
combined with chemometric methods are applied in 
cancer screening. The related research work is 
expected to carry out systematically. In this paper, 
uncorrelated linear discriminant analysis (ULDA) was 
used to find the best classification of subspace and 
characteristic variables and applied to 17 kinds of 
amino acid content data in the serum of cancer patients 
and healthy people. 
 
Feature extraction and dimension reduction are very 
important in data processing. Many methods have been 
proposed for feature reduction
9-13
, such as principal 
component analysis (PCA), partial least squares- 
discriminate analysis (PLS-DA), k-means cluster 
analysis, and linear discriminant analysis (LDA) etc. 
Uncorrelated linear discriminant analysis
14-19
 was first 
put forward by Jin and others in the field of face 
recognition. Now it has been successfully applied in 
the data of metabolomics, proteomics and gene 
expression profile. ULDA algorithm based on linear 
discriminant analysis aims to find discriminant 
directions by maximizing the distance between two 
target classes and simultaneously minimizing the 
distance between the Universum and the mean of the 
target classes. 
 
The results of this article showed that the cancer 
patients and healthy people were identified completely 
by ULDA modeling to 17 kinds of amino acid content 
data. And several characteristic amino acid biomarkers 
were chosen by compared with a significant difference 
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through the mean equation of t-test. It indicates that 
ULDA is an effective feature extraction and 
dimension reduction method, and applied to the 
analysis of amino acids levels in serum, possibly 
provides a new cancer identification method and 
possibly gives new potential tumor biomarkers. 
 
 
Materials and Methods 
 
Materials 
Chinese People's Liberation Army 252th Hospital 
provided serum of 31 healthy people and 50 lung 
cancer patients (age range from 22 to 83). The 17 kinds 
of free amino acids in serum were detected by high 
performance liquid chromatography (HPLC) instrument 
including aspartic acid (ASP), glutamate (GLU), 
histidine (HIS), serine (SER), arginine (ARG),  
glycine (GLY), threonine (THR), taurine (TAU),  
proline (PRO), alanine (ALA), valine (VAL), 
methionine (MET), cystine (CYS), isoleucine (ISO), 
leucine (LEU), phenylalanine (PHE), lysine (LYS). 
Agilent 1200 high performance liquid 
chromatography (American Agilent company); Kromat 
Universal C18 column (The United States); Ultrasonic 
broken instrument (Branson S-450D, America); The 
thermostatic water bath pot (Beijing changfeng 
instrument co., Ltd); pH meter (Mettle Toledo 
instrument co., Ltd., Shanghai; LE438 pH electrode); 
17 kinds of amino acid standard substances  
(Ltd. Wako, Japan). 
Amino acids were determined by HPLC with  
2,4-dinitrochlorobenzene derivatization. Gradient 
elution was adopted with mobile phase A of acetonitrile 
and mobile phase B of acetic acid-sodium acetate buffer 
(pH 5.25). The flow rate was 1 mL/min and the injection 
volume was 10 μL. The column temperature was 40C 
and the detection wavelength was 360 nm. 
 
Chemometric method 
ULDA aims to find an optimal transformation matrix 
G. The data X in high dimensional space is projected 
into low dimensional space, as well as maximize the 
Fisher discriminant equation with constraint condition. 
ULDA algorithm considers uncorrelated between 
column vectors on the transformation matrix based on 
LDA, so it can reduce the data redundancy after 
dimension reduction. The uncorrelated discriminant 
vector (UDV) in dimension reduction space is a linear 
combination of the variables in an original high 
dimensional space, and the coefficient of combination 
depends on the transformation matrix G. Then the new 
low dimensional matrix Z can be calculated by  
Z = XG
20
. 
Statistical analysis 
The method of t-test (also called Student's t-test in 
statistics) is also used in this study. A t-test is any 
statistical hypothesis test in which the test statistic 
follows a Student's t-distribution if the null hypothesis 
is supported. It is used to determine the probability (p) 
that two populations are the same in respect to the 
variable that you are testing, that is if two sets of data 
are significantly different from each other
21,22
.  
Matlab 7.0 and SPSS 19.0 were used as the 
calculation software. 
 
Results and Discussion 
 
The results of the ULDA method 
Firstly, the sample data were divided into two parts. 
25 samples of cancer patients and 15 samples of 
healthy people were arbitrarily chosen to modeling, 
and the other 25 samples of cancer patients and  
16 samples of healthy people were used to prediction. 
Because a number of categories is two, only one 
uncorrelated discriminant vector was obtained, and 
transformation matrixes G was also one line. So data 
visualization in two-dimensional spatial was achieved, 
consequently, the complexity of the model was 
decreased and explain the ability of the model was 
enhanced. The uncorrelated discriminant vectors of 
samples obtained are shown in (Fig. 1).  
In the data of amino acids levels, the 30
th
 sample of 
healthy people was a bad sample, which had become 
red and cloudy obviously due to improper storage. 
Also, amino acids levels of this sample are mostly 
 
 
Fig. 1 — Uncorrelated discriminant vectors of ULDA (“ + ”: 
modeling samples of cancer patients; “ * ”: modeling samples of 
healthy people; “ o ”: prediction samples of cancer patients; “ · ”: 
prediction samples of healthy people) 
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much lower than those of other normal samples. In 
(Fig. 1), a sample deviation is clearly found, which is 
just the 30
th
 sample of healthy people. So it is seems 
that ULDA can be used as a good method of judging 
for the singular sample. 
In the rest 80 samples data after the bad sample 
was deleted, in the same way, 25 samples of cancer 
patients and 15 samples of healthy people were 
arbitrarily chosen to modeling. The other 25 samples 
of cancer patients and 16 samples of healthy people 
were used to prediction. The analysis results are 
shown in (Fig. 2). 
It can be clearly seen from (Fig. 2), the UDVs got 
by ULDA can completely distinguish cancer patients 
and healthy people. The classification accuracy rate 
reaches 100%, which means that the method of 
ULDA combined with amino acids levels could be 
applied in cancer detection. 
In (Fig. 3), transformation matrixes G of 17 
variables were presented, in which biomarkers could be 
clearly and precisely selected. Several variables with 
high absolute values were chosen and marked in the 
figure, which is successively valine, threonine, 
leucine, phenylalanine, and histidine.  
 
The results of statistical processing 
Then, statistical processing was adopted to analyze 
the data. The determination results of amino acids were 
expressed by “mean  standard deviation”, and t-test 
was used to find amino acid with a significant 
difference between the data of cancer patients and 
healthy people. The corresponding analysis results are 
given in (Table 1). 
According to (Table 1), firstly, it can be seen that the 
mean levels of 5 kinds of free amino acids in serum 
including GLU, SER, ARG, MET and PHE in the 
cancer group are higher than those of normal group. 
Levels of other amino acids in cancer group are mostly 
lower than those of normal group. The results proved 
"nitrogen trap" phenomenon of the high demand of 
amino acids by a malignant tumor. 
Secondly, levels of SER, THR, TAU, ALA and 
CYS in the cancer group compared with those of 
normal group, there was no statistically significant 
 
 
Fig. 2 — Uncorrelated discriminant vectors of ULDA without  
the bad sample (“ + ”: modeling samples of cancer patients; “ * ”: 
modeling samples of healthy people; “ o ”: prediction samples of 
cancer patients; “ · ”: prediction samples of healthy people) 
 
 
 
Fig. 3 — Transformation matrix of ULDA 
Table 1—Serum amino acid levels of cancer patients compared 
with normal group (mg/L, x ±s) 
Amino acid Normal group 
(n=30) 
Cancer group 
(n=50) 
t 
ASP 14.590.21 12.580.42 4.256 (P = 0.001) 
GLU 13.460.28 15.390.43 -3.727 (P =0 .002) 
HIS 10.550.15 7.180.21 12.794 (P = 0.000) 
SER 19.100.46 21.100.90 -1.974 (P = 0.052) 
ARG 8.230.25 11.860.39 -7.827 (P = 0.000) 
GLY 19.810.35 18.320.52 2.370 (P = 0.020) 
THR 11.060.27 11.540.42 -0.979 (P = 0.331) 
TAU 10.130.22 9.780.38 0.794 (P = 0.430) 
PRO 13.870.24 11.810.37 4.657 (P = 0.001) 
ALA 27.860.52 27.600.56 0.347 (P = 0.729) 
VAL 26.740.31 15.640.42 21.061 (P = 0.000) 
MET 0.480.09 1.170.23 -2.804 (P =0.007) 
CYS 0.010.002 0.010.003 -0.044 (P = 0.965) 
ISO 5.090.11 4.220.22 3.493 (P = 0.001) 
LEU 16.910.24 11.460.28 14.672(P = 0.000) 
PHE 4.580.12 6.180.15 -8.258(P = 0.000) 
LYS 0.840.06 3.920.73 -4.207(P = 0.002) 
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difference (P >0.05). Other amino acids levels all 
show significant differences between cancer patients 
and normal group, especially amino acids of HIS, 
ARG, VAL, LEU and PHE (P = 0.000). Comparatively, 
VAL, THR, LEU, PHE and HIS were chosen by 
ULDA. So the results of the t-test method verify that 
ULDA could be used to select potential tumor 
biomarkers distinguishing cancer patients and healthy 
people. 
 
Conclusion 
Analysis of free amino acid level in serum combined 
with the chemometric method of ULDA applied to the 
classification of cancer patients and healthy people, and 
as well as an exploration of potential tumor biomarker. 
The method has certain practical significance and 
application prospects.  
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